Literature DB >> 11165090

Production and evaluation of size reduced grades of microcrystalline cellulose.

S R Levis1, P B Deasy.   

Abstract

Size reduction of microcrystalline cellulose (MCC, Avicel PH-101) powder by ball milling was poorly effective, particularly in the presence of sodium lauryl sulphate (SLS), which tended to form a protective foam. Ultrasonic homogenisation of an aqueous suspension more readily produced ultra-fine MCC, even in the presence of the surfactant and two other de-aggregating agents, and factorial experimentation was used to optimise the process. The product was recovered by spray-drying and readily redispersed in water without re-aggregation. Two new grades of ultra-fine MCC, prepared by an optimised treatment with or without 1% SLS, were characterised by a range of techniques in comparison to the starting coarser grade, Avicel PH-101. Mercury porosimetry and scanning electron microscopy confirmed the less porous and smaller particle size of the new grades, where deposition of SLS as a coating was evident. Surface area determination confirmed that the size-reduced grades had larger specific surface areas, particularly the SLS treated material. Low temperature DSC and X-ray diffraction studies suggested that the new ultra-fine grades were more amorphous. Collectively the results indicate that the new grades should have unique functionality, possibly of benefit in pharmaceutical formulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11165090     DOI: 10.1016/s0378-5173(00)00652-9

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  1 in total

Review 1.  Potential Applications of Nanocellulose-Containing Materials in the Biomedical Field.

Authors:  Nadia Halib; Francesca Perrone; Maja Cemazar; Barbara Dapas; Rossella Farra; Michela Abrami; Gianluca Chiarappa; Giancarlo Forte; Fabrizio Zanconati; Gabriele Pozzato; Luigi Murena; Nicola Fiotti; Romano Lapasin; Laura Cansolino; Gabriele Grassi; Mario Grassi
Journal:  Materials (Basel)       Date:  2017-08-21       Impact factor: 3.623

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.